epirubicin , the new anthracycline derivate and analogue of doxorubicin ( probably the most active chemotherapeutic agent against breast cancer ) exhibits the same high activity but lower side-effects compared with the parent compound .
C0014582
epirubicin
C0013089
doxorubicin